Vol. 4, No. 7, p. 45-52 - Jun. 30, 2017
Aqueous extract of bitter leaf Vernonia amygdalina Delile (Asterales: Asteraceae) ameliorates testosterone-induced benign prostatic hyperplasia (BPH) in Wistar rats
Abayomi Ajayi
 , 
     Titilayo Ige
, 
     Titilayo Ige  , 
     Nich Arawa Ude
, 
     Nich Arawa Ude  , 
     Olusegun Dare Omotoso
, 
     Olusegun Dare Omotoso  Gbenga Olorunshola Alege
     Gbenga Olorunshola Alege  , 
     John Oluwagbenga Balogun
, 
     John Oluwagbenga Balogun  , 
     Ekanem Ikanna Asuquo
, 
     Ekanem Ikanna Asuquo  and 
     Akpovughaye Taiga
 and 
     Akpovughaye Taiga 
Abstract
Benign prostatic hyperplasia (BPH) is an age-dependent condition involving prostate enlargement which may lead to lower urinary tract symptoms (LUTS). This study was designed to study the ameliorative effect of the aqueous extract of bitter leaf Vernonia amygdalina Delile (Asterales: Asteraceae) on testosterone-induced BPH in a rat model. Thirty adult male Wister rats were randomly divided into six groups (A to F), with BPH induced through a single subcutaneous injection of 5 mg/kg of testosterone propionate (TP) and Vernonia amygdalina administered in various doses through oral gavage for 14 days. Group A (control) was administered with distilled water only, group B with 5 mg/kg of TP only, group C with 5 g/mL of V. amygdalina only, group D with 5 mg/kg of TP and 5 g/mL of V. amygdalina, group E with 5 mg/kg of TP and 7.5 g/mL of V. amygdalina and group F with 5 mg/kg of TP and 10 g/ml of V. amygdalina. Results show that testosterone caused histological changes that are similar to the presentation of BPH in the prostate. Aqueous extract of V. amygdalina was observed to ameliorate testosterone-induced histological changes and prostatic parameters especially at higher concentration. This suggests that bitter leaf could be a candidate herb for the treatment of BPH.
     
     Keywords
     Benign prostatic hyperplasia; Testosterone; Bitter leaf; Vernonia amygdalina; Prostate gland.
     
     DOI
     10.21472/bjbs.040706
     
     Full text
     PDF
     
     References
     Abraham, K.; Ajayi, A. Benign prostatic hyperplasia: role of estrogen and putative therapeutic effect of selective estrogen 
     receptor modulators. Proceedings of the Physiological Society of Nigeria, 28, 2014. Available from: <http://www.physoc.org/proceedings/abstract/Proc Physiol Soc 31C55>. 
     Accessed on: Feb. 20, 2017.
     
     Chan, S. W. Pathology and medical therapy of benign prostatic hyperplasia. The Hong Kong Medical Diary, v. 16, No. 6, 
     p. 4-8, 2011. https://dx.doi.org/10.4236/ojmm.2015.51004
     
     Chou, C.-L. Current medical treatment for benign prostatic hyperplasia/lower urinary tract symptoms. Incont. Pelvic Floor Dysfunct, 
     v. 1, No. 2, Suppl. 2, p. 15-19, 2007. Available from: <http://www.tcs.org.tw/issue/folder/1_2suppl/1-suppl 2-15-19.pdf>. 
     Accessed on: Feb. 20, 2017.
     
     Dhingra, N.; Bhagwat, D. Benign prostatic hyperplasia: an overview of existing treatment. Indian Journal of Pharmacology, v. 43, 
     No. 1, p. 6-12, 2011. https://dx.doi.org/10.4103/0253-7613.75657
     
     Eisenberg, D. M.; Kessler, R. C.; Foster, C.; Norlock, F. E., Calkins, D. R.; Delbanco, T. L. Unconventional medicine in the United States. 
     New England Journal of Medicine, v. 328, p. 246-252, 1993. https://dx.doi.org/10.1056/NEJM199301283280406
     
     Eleyinmi, A. F.; Sporns, P.; Bressler, D. C. Nutritional composition of Gongronema latifolium and Vernonia amygdalina. Nutr. 
     Food Sci., v. 38, p. 99-109, 2008. https://dx.doi.org/10.1108/00346650810862975
     
     Erasto, P.; Grierson, D. S.; Afolayan, A. J. Bioactive sesquiterpene lactones from the leaves of Vernonia amygdalina. J. Ethnopharmacol., 
     v. 106, p. 117-120, 2006. https://dx.doi.org/10.1016/j.jep.2005.12.016
     
     Hutchinson, J.; Dalziel, M. J. Floral of West Tropical Africa. 2. ed. London: Crown Agent for Overseas Government and Administrations, 1963. 
     v. 2. p. 225-297.
     
     Ijeh, I. I.; Ejike, C. E. C. C. Current perspectives on the medicinal potentials of Vernonia amygdalina Del. Journal of Medicinal Plants 
     Research, v. 5, No. 7, p. 1051-1061, 2011. Available from: <http://www.academicjournals.org/article/article1380529017_Ijeh and Ejike.pdf>. 
     Accessed on: Feb. 20, 2017.
     
     Kapoor, A. Benign Prostatic Hyperplasia (BPH) management in the primary care setting. The Canadian Journal of Urology, v. 19, No. 1, p. 10-17, 
     2012. Available from: <http://www.canjurol.com/html/free-articles/V19I5S1F-03-DrKapoor.pdf>. 
     Accessed on: Feb. 20, 2017.
     
     Lasekan, O. O.; Lasekan, W. O.; Babalola, J. O. Effect of Vernonia amygdalina (bitter leaf) extract on brewing qualities and amino acid 
     profiles of stout drink from sorghum and barley malts. Food Chemistry, v. 64, p. 507-510, 1998. https://dx.doi.org/10.1016/S0308-8146(98)00148-4
     
     Okoh, I. A.; Babalola, G. O.; Ilori, M. O. Effect of methanol extract of Vernonia amygdalina on malting and brewing properties of sorghum. 
     Tech. Q. Master Brew. Assoc. Am., v. 32, No. 1, p. 11-14, 1995.
     
     Okoli, R. I.; Aigbe, O.; Ohafu-Obode, J. O.; Mensah, J. K. Medicinal herbs used for managing some common ailments among Esan People Edo State, 
     Nigeria. Pakistan Journal of Nutrition, v. 6, No. 5, p. 470-490, 2007. https://dx.doi.org/10.3923/pjn.2007.490.496
     
     Oluwalana, S. A.; Adekunle, M. F. Forest plant roots in household nutrition and health care in Abeokuta, Ogun State, Nigeria. J. Trop. for 
     Resources, v. 1, p. 120-136, 1998.
     
     Onyechi, O.; Elom, S.O.; Chukwunonso E. C. C. Prostate problems with aging, prevention and treatment prospects. Unique, p. 45-50, 2012.
     
     Rice-Evans, C. A.; Miller, N. J.; Paganga, G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic. Biol. 
     Med., v. 20, p. 933-956, 1996. https://doi.org/10.1016/0891-5849(95)02227-9
     
     Suzuki, K. Epidemiology of prostate cancer and benign prostatic hyperplasia. Journal of Medical Association of Japan, v. 52, No. 6, 
     p. 478-483, 2009. Available from: <https://www.med.or.jp/english/journal/pdf/2009_06/478_483.pdf. 
     Accessed on: Feb. 20, 2017.
     
     
     
     
 
        



